GNH USA

USA — NDC

Trijardy XR 5 mg/1

Trijardy XR 5 mg/1 is a combination medication containing empagliflozin, linagliptin, and metformin hydrochloride. It is designed to help manage blood sugar lev

Empagliflozin, Linagliptin, Metformin Hydrochloride
Trijardy XR
TABLET, EXTENDED RELEASE
5 mg/1

Request sourcing

1
Pack/s

What is Empagliflozin, Linagliptin, Metformin Hydrochloride?

Trijardy XR 5 mg/1 is a combination medication containing empagliflozin, linagliptin, and metformin hydrochloride. It is designed to help manage blood sugar levels in adults with type 2 diabetes. This extended-release tablet offers a convenient once-daily option for those requiring multiple therapies in a single dose.

What is Empagliflozin, Linagliptin, Metformin Hydrochloride used for?

Trijardy XR 5 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It combines three active ingredients: empagliflozin, which helps the kidneys remove excess glucose from the body; linagliptin, which works to increase insulin production; and metformin hydrochloride, which reduces the amount of sugar released by the liver. This medication is often prescribed when diet and exercise alone are not sufficient to manage blood sugar levels. People often ask, 'What is Trijardy XR used for?' and the answer is it is used as part of a comprehensive diabetes management plan.

What are the side effects of Empagliflozin, Linagliptin, Metformin Hydrochloride?

Common effects of Trijardy XR 5 mg/1 may include symptoms such as headache, nausea, diarrhea, and upper respiratory tract infection. Some individuals may experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. It is important to monitor blood sugar levels regularly and consult a healthcare provider if any persistent or severe side effects occur.

What precautions apply to Empagliflozin, Linagliptin, Metformin Hydrochloride?

Trijardy XR 5 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients with a history of kidney problems, pancreatitis, or lactic acidosis should discuss their medical history with their healthcare provider before starting this medication. Regular monitoring of kidney function and blood sugar levels is recommended.

What does Empagliflozin, Linagliptin, Metformin Hydrochloride interact with?

Trijardy XR 5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. It is also important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

Frequently asked questions

What is Trijardy XR 5 mg/1 used for?+
Trijardy XR 5 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.
How should Trijardy XR 5 mg/1 be taken?+
Trijardy XR 5 mg/1 is an extended-release tablet that should be taken orally, typically once daily, with a meal.
What are the common side effects of Trijardy XR 5 mg/1?+
Common side effects may include headache, nausea, diarrhea, and upper respiratory tract infection.
Can Trijardy XR 5 mg/1 be taken with other medications?+
It is important to consult a healthcare provider before taking Trijardy XR 5 mg/1 with other medications to avoid potential interactions.
Is Trijardy XR 5 mg/1 suitable for everyone with type 2 diabetes?+
Trijardy XR 5 mg/1 is not suitable for everyone. Patients with certain medical conditions should discuss their suitability with a healthcare provider.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Empagliflozin, Linagliptin, Metformin Hydrochloride
Brand
Trijardy XR
Strength
5 mg/1
Form
TABLET, EXTENDED RELEASE
Route
ORAL
Pack size
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Origin
USA

Related products